Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and
Vaccines have had broad medical impact, but existing vaccine technologies and production methods are limited in their ability to respond rapidly to evolving and emerging pathogens, or sudden outbreaks. Here, we develop a rapid-response, fully synthetic, singledose, adjuvant-free dendrimer nanopartic...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
National Academy of Sciences (U.S.)
2018
|
| Online Access: | http://hdl.handle.net/1721.1/114728 https://orcid.org/0000-0003-3811-2369 https://orcid.org/0000-0003-4255-0492 https://orcid.org/0000-0001-5629-4798 |